KYUNG NAM PHARM financial statements, including revenue, expenses, profit, and loss

The total revenue of 053950 for the last quarter is 20.54 B KRW, and it's 21.35% higher compared to the previous quarter. The net income of Q4 23 is -15.10 B KRW.